Osteotech (OSTE)


"Osteotech, Inc. is a global leader in the processing of human bone and connective tissue for transplantation and an innovator in the development, manufacturing and marketing of biologic, biomaterial and device systems for musculoskeletal surgery. With a particular focus on spinal, trauma, and total joint revision procedures, the Company's current and development-stage technologies address needs within numerous musculoskeletal disciplines." (company website)

OSTE 1-year chart
OSTE 1-year chart


OSTE 2-month chart OSTE 2-month chart

Osteotech barely budged in the market freefall at the end of February and got a boost from its earnings report a week later.

  • Price momentum (PPO) — has fallen off since hitting another new 52-week high
  • Trend (ADX) — still strong with buying pressure (+DI) and selling pressure (-DI) evenly balanced
  • Money flow (CMF) — strong inflow has subsided a bit since new high
  • Relative strength (RSI) — drew back to neutral, but is strengthening again
  • Volume — much higher daily volumes since early February

Based on technical analysis, MarketEdge calls OSTE a "strong buy" in a "strong upward trend."


gain Bottom line

When I had a chance to look in on the market this morning, OSTE was taking a plunge for the third straight day, so I quickly sold to preserve a modest profit.